Chlorella and the Broader Microalgae Protein Landscape

Animal & protein

What it is

Chlorella is a genus of single-celled green algae (not cyanobacteria like spirulina — genuine eukaryotic algae with a cell nucleus) that was one of the first microorganisms studied systematically as a potential mass food source. Its protein content approaches 50–60% of dry weight, it contains all essential amino acids, and it grows rapidly in both open ponds and closed photobioreactor systems.

History & domestication

Chlorella entered scientific consciousness in the late 19th century when the Dutch botanist Martinus Beijerinck first isolated and identified it in 1890. But its food potential attracted serious attention only during and after World War II, when food security concerns in both Germany and the United States led to government-funded research programs exploring algae as a protein source. The Carnegie Institution in Washington, D.C. conducted significant chlorella production research in the late 1940s; simultaneously, Japanese scientists were developing chlorella production as a response to postwar food shortages.

Japan became the world center of chlorella production and consumption through the 1950s and 1960s. Japanese producers developed large-scale cultivation systems and mass-marketed chlorella tablets as health supplements, capitalizing on a domestic consumer market that was receptive to concentrated nutritional supplements in compressed form. By the 1970s, Japan had a substantial chlorella supplement industry that has persisted to the present — Japanese per-capita consumption of chlorella dietary supplements remains the highest in the world.

In the 1950s, researchers at several American institutions studied chlorella as a potential space food. The photosynthetic metabolism of chlorella — consuming CO2 and producing O2 — made it theoretically valuable as a component of a closed-loop life support system for space missions. Stanford University, the Carnegie Institution, and MIT all conducted research programs; the Atomic Energy Commission funded studies on producing chlorella using nuclear energy as a power source. These programs did not produce commercially viable outcomes, but they established a significant body of scientific literature on chlorella cultivation and nutrition.

The nutritional profile

Chlorella's nutritional proposition is similar to spirulina's but with some distinct differences:

Protein: 50–60% of dry weight; all essential amino acids present
Chlorophyll: Among the highest chlorophyll concentrations of any known organism — a fact prominently featured in health food marketing, though the nutritional significance of dietary chlorophyll for humans is limited
Vitamin B12: Chlorella contains genuine, bioavailable B12 (as methylcobalamin and adenosylcobalamin), unlike spirulina's B12 analogs. This makes chlorella a genuinely valuable dietary supplement for vegans, who often struggle to obtain B12 from non-animal sources.
Nucleic acids: Like spirulina, chlorella has high nucleic acid content that requires management at high intake levels to avoid raising uric acid.
Chlorella Growth Factor (CGF): A complex extract from the nucleus of chlorella cells, marketed extensively in Japan as a health supplement. CGF contains nucleotides, peptides, and polysaccharides. The specific health claims made for CGF (accelerated healing, anti-aging, immune stimulation) have highly variable evidence quality and should be treated with appropriate skepticism.

The cell wall challenge

Chlorella's primary processing challenge is its cell wall, which is made of a highly indigestible sporopollenin-like polymer. Raw, unprocessed chlorella powder has significantly reduced protein bioavailability because the cell walls prevent digestive enzymes from accessing the protein inside. Effective chlorella products must use cell-disruption processing — mechanical breaking of the cell wall using high-pressure homogenization, bead milling, or spray drying under shear stress — to maximize digestibility. "Broken cell wall" chlorella products, which have undergone this processing, are substantially more nutritionally available than untreated powder.

The flavor challenge

Chlorella's flavor is if anything more challenging than spirulina's — intensely green, grassy, and with a persistently earthy-algal character that is even more difficult to mask in food products. This has largely confined chlorella to the supplement market rather than the food ingredient market in the West, though it is used in small quantities in "green" food products where its color and nutritional credential are the selling point.

The wider microalgae protein landscape

Beyond spirulina and chlorella, a broader microalgae protein landscape is developing:

Nannochloropsis and Isochrysis: Marine microalgae with high omega-3 fatty acid content (EPA and DHA in nutritionally significant quantities). These species are cultivated commercially primarily for their lipid content rather than their protein, but the protein-rich biomass remaining after lipid extraction is a high-value co-product with potential as a food ingredient. The primary commercial application of these algae is as an alternative to fish oil in omega-3 supplementation — an application that Martek Biosciences pioneered in the 1990s and that several subsequent companies have expanded.

Haematococcus pluvialis: A green alga that accumulates astaxanthin — a carotenoid pigment with high antioxidant activity — as a stress response. Astaxanthin is used as a dietary supplement and as an aquaculture feed ingredient (giving farmed salmon their pink color, which wild salmon derive from astaxanthin in the crustaceans they eat). The protein content of Haematococcus biomass is a co-product of astaxanthin extraction.

Diatoms: Silica-shelled photosynthetic algae that dominate marine phytoplankton communities. Diatoms contain all essential amino acids and their amino acid profile is favorable, but their silica cell wall creates processing challenges analogous to (and more severe than) chlorella's cell wall.

The future of algae protein

The fundamental ecological case for microalgae as a protein source — high protein yield per unit of land and water, photosynthetic CO2 fixation, potential to grow on non-potable water, no competition with food crop land — remains compelling, and the scientific interest in improving algae production economics has been sustained. But the transition from compelling ecological case to practical, affordable, palatable food protein has proved more difficult than early promoters anticipated.

The flavor challenge is the most immediate barrier. The economic challenge is also significant: open pond production is limited to warm climates and is subject to contamination and productivity variability; closed photobioreactor production is scalable and consistent but currently substantially more expensive than open pond production.

The algae protein companies and research institutions working on this transition include:

Corbion: A Dutch biotechnology company producing algae-derived food ingredients including astaxanthin and algae proteins
Roquette: A French starch and protein company with significant algae research programs
Qualitas Health (now iwi): A Texas-based company producing Nannochloropsis-derived omega-3 products with a significant algae cultivation operation
AlgaVia (now part of TerVia, itself acquired by DSM): Developed whole algae flour and algae-derived lipid products

The trajectory of algae protein is toward food ingredient applications rather than direct food consumption, primarily because the flavor challenge makes direct eating of algae difficult. As an ingredient — purified, deodorized, and incorporated into other food products — microalgae protein concentrates have significant potential.

Reference notes

Cross-link to: Spirulina, Omega-3 Fatty Acids, Aquaculture (farmed salmon), Astaxanthin, Novel Protein overview
Tags: Novel Protein, Algae, Microalgae, Complete Amino Acids, Omega-3, B12 Source (Chlorella)

---